More On

Canada Supreme Court strikes down Pfizer’s Viagra patent

According to ruling, Pfizer did not provide enough details about the drug’s active ingredient

World, if there is one thing I would criticize you for, it is that you are not filled with enough erectile dysfunction drugs. But luckily, the Canada Supreme Court is here to help. On Thursday, it struck down Pfizer Inc.’s patent on Viagra, opening the door for generic competition.

Teva Pharmaceutical Industries Ltd., the largest generic drug maker in the world, argued that Pfizer was too vague when it filed its patent. The court agreed, unanimously, and in its 7-0 verdict wrote that Pfizer did not provide adequate details identifying Viagra’s active ingredient, and ended the company’s patent on the drug just less than two years away from when it would have run out anyway in 2014.

Join the Conversation

Advertisement. Closing in 15 seconds.